Nomura Asset Management Co. Ltd. lifted its position in The Clorox Company (NYSE:CLX - Free Report) by 10.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 333,839 shares of the company's stock after purchasing an additional 32,572 shares during the quarter. Nomura Asset Management Co. Ltd. owned about 0.27% of Clorox worth $54,386,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $27,000. Innealta Capital LLC acquired a new position in shares of Clorox in the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC grew its holdings in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after purchasing an additional 130 shares during the period. Family Firm Inc. acquired a new stake in shares of Clorox during the 2nd quarter worth about $31,000. Finally, Quarry LP raised its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after buying an additional 114 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have weighed in on CLX. Barclays increased their target price on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research note on Friday, November 1st. DA Davidson increased their target price on Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research note on Monday, November 4th. Citigroup lifted their target price on Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. BNP Paribas upgraded shares of Clorox to a "strong sell" rating in a research note on Friday, September 6th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research note on Friday, October 11th. Five investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $155.00.
View Our Latest Stock Report on Clorox
Clorox Stock Up 0.2 %
CLX stock traded up $0.33 during trading on Tuesday, hitting $167.73. 979,205 shares of the company's stock were exchanged, compared to its average volume of 1,232,507. The business has a 50-day moving average price of $163.59 and a two-hundred day moving average price of $150.86. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market capitalization of $20.76 billion, a price-to-earnings ratio of 58.42, a PEG ratio of 3.08 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the firm earned $0.49 EPS. The company's revenue was up 27.0% compared to the same quarter last year. As a group, equities research analysts expect that The Clorox Company will post 6.85 EPS for the current year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio (DPR) is currently 170.04%.
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.